CARDIOMYOPATHIES

Saturday, March 8, 2025

2:10 PM – 3:05 PM ET

Moderator(s)

Rachel Barish, NP

Program Director, Infiltrative Cardiomyopathy
MedStar Health

Disclosure(s): AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 28, 2024); Johnson and Johnson: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Merck & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Ahmed Khan, MD, MS

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose
David Xu, MD

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Rachel Barish, NP: AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 28, 2024); Johnson and Johnson: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Merck & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Ahmed Khan, MD, MS: No financial relationships to disclose

David Xu, MD: No financial relationships to disclose